Document is current
Any future updates will be listed below
-
Authors
Kolinger, Guilherme D.
Vállez García, David
Lohith, Talakad G.
Hostetler, Eric D.
Sur, Cyrille
Struyk, Arie
Boellaard, Ronald
Koole, Michel https://orcid.org/0000-0001-5862-640X
-
Funding
Funding for this research was provided by:
H2020 Marie Skłodowska-Curie Actions (764458)
- License Information
-
More Information
Article History
Received: 23 November 2020
Accepted: 17 May 2021
First Online: 27 May 2021
Declarations
:
: The study was conducted at the University Hospital Leuven, Belgium, and approved by the local Ethics Committee (University Hospitals Leuven/KU Leuven, ClinicalTrials.gov no. NCT02562989). The subjects (or legal representative) gave written informed consent before enrollment in the study.
: All authors consent for publication and all subjects enrolled in the study agreed for their data to be used for further analyses.
: TGL, EDH, CS, and AS are or were employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Kenilworth, NJ USA, at the time of the study and may own stock and/or hold stock options in the Company.
